Vascular Medicine and Chronic Limb-Threatening Ischemia
Clinical research at Fondation Hopital Saint Joseph includes chronic limb-threatening ischemia in patients with Rutherford category 4 or 5, with attention to distal revascularization and below-the-knee endovascular therapy.
- Peripheral arterial disease
- Amputation-free survival
- Dual antiplatelet therapy
- Rivaroxaban in vascular care
The sponsor’s vascular activity is centered on outcomes relevant to limb preservation and long-term survival in advanced lower-extremity ischemia.
Pulmonary Hypertension and Right Heart Surgery
Another active area is chronic thromboembolic pulmonary hypertension, with research linked to pulmonary artery endarterectomy and immediate changes in mean pulmonary arterial pressure.
- Chronic thromboembolic pulmonary hypertension
- Pulmonary artery endarterectomy
- Mean pulmonary arterial pressure
- Post-operative hemodynamics
This clinical focus reflects interest in perioperative management for complex pulmonary vascular disease.
Perioperative Hemodynamic Management
Research also addresses vasopressor therapy in the surgical setting, comparing agents used to control pulmonary arterial pressure after major cardiothoracic intervention.
- Vasopressin
- Norepinephrine
- Hemodynamic stabilization
- Post-operative cardiovascular support
The sponsor’s interest extends to immediate post-surgical physiology and management strategies in pulmonary vascular procedures.
